About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Ovarian Cancer Clinical Trials | 4,055 Studies Recruiting

Clinical TrialsOvarian Cancer

Ovarian Cancer Clinical Trials

Browse 4,055 clinical trials for ovarian cancer. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 4021-4040 of 4,055 trials

CompletedHysterectomy for Benign Gynaecological Conditions With or Without TubectomyThe purpose of this study is to determine whether a tubectomy during hysterectomy for benign gynaecological conditions does not result into a premature menopause.NCT02281487·Nijmegen, Gelderland and 4 others UnknownVenous Thromboembolic Complications in Ovarian CancerObjectives of the study are: To estimate the incidence of venous thromboembolism (VTE) in a cohort of women with suspected ovarian cancer and evaluate changes in the coagulation…NCT02480790·Aalborg RecruitingOpen-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced CancerIncyclix Bio (Incyclix) is developing INX-315 as an oral, small molecule inhibitor of cyclin dependent kinase 2 (CDK2) for the treatment of human cancers.NCT05735080·Orlando, Florida and 17 others

Related Searches

ovary cancertrials

Data from ClinicalTrials.govTerms

Not yet recruitingAn Open-label, Single-arm Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Profile, and Preliminary Efficacy of KT032 Cell Injection in Patients With Mesothelin-positive Advanced Solid Tumors.An Open-label, Single-arm Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Profile, and Preliminary Efficacy of KT032 Cell Injection in Patients With…NCT07420010

CompletedA Clinical Study of Cobimetinib Administered in Combination With Niraparib, With or Without Atezolizumab to Patients With Advanced Platinum-sensitive Ovarian CancerThe study will include a safety run-in phase (Stage 1) and a randomization phase (Stage 2).NCT03695380·Tucson, Arizona and 19 others

TerminatedMT2021-27 FT538 Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal CancerTo determine the maximum tolerated dose (MTD) of FT538 monotherapy when administered via intraperitoneal (IP) catheter and in combination with intravenous (IV) enoblituzumab in…NCT05708924·Minneapolis, Minnesota

CompletedGlycan Mediated Immune Regulation With a Bi-Sialidase Fusion Protein (GLIMMER-01)This is a Phase 1/2, first-in-human, open-label, dose escalation and dose-expansion study of E-602, administered alone and in combination with cemiplimab.NCT05259696·La Jolla, California and 12 others

RecruitingA Clinical Study of SYS6041 Combination Therapy for Recurrent Ovarian CancerThis is an open-label, multicenter Phase II clinical study conducted in subjects with recurrent ovarian cancer.NCT07714668·Shanghai, Shanghai Municipality

TerminatedA Study of MEK162 vs. Physician's Choice Chemotherapy in Patients With Low-grade Serous Ovarian, Fallopian Tube or Peritoneal CancerThe MILO Study (MEK Inhibitor in Low-grade Serous Ovarian Cancer) is a Phase 3 study during which patients with recurrent or persistent low-grade serous (LGS) carcinomas of the…NCT01849874·Phoenix, Arizona and 225 others

CompletedImplementing Enhanced Recovery After Surgery (ERAS) Pathways In Major Gynecologic Oncology Operations In GreeceThe Enhanced Recovery After Surgery (ERAS) program includes preoperative counseling, fasting avoidance, non-opioid analgesia, fluid balance, normothermia and early mobilization.NCT04696276·Athens, Attica

CompletedA Study to Assess the Efficacy and Safety of Farletuzumab (MORAb 003) in Combination With Carboplatin Plus Paclitaxel or Carboplatin Plus Pegylated Liposomal Doxorubicin (PLD) in Participants With Low CA125 Platinum-sensitive Ovarian CancerMORAb-003-011 is a global, multicenter, double-blind, randomized placebo-controlled study to assess the safety and efficacy of farletuzumab in combination with standard…NCT02289950·Phoenix, Arizona and 67 others

Active not recruitingA First-in-human Dose Escalation and Expansion Study to Evaluate the Safety, and Tolerability of AZD8421 Alone or in Combination in Participants With Selected Advanced or Metastatic Solid TumorsThis study is designed to evaluate AZD8421 alone and in combination with selected targeted anti-cancer drugs in patients with ER+HER2- advanced breast cancer, and patients with…NCT06188520·St Louis, Missouri and 12 others

CompletedFeasibility of Interval Debulking Surgery by Laparoscopy for Peritoneal Carcinosis in Chemosensitive PatientsThis prospective nonrandomized multicenter phase II study, will evaluate the possibility of performing a laparoscopic interval debulking after a minimum of 3 cycles of…NCT01905163·Angers and 9 others

CompletedVaccine Therapy in Treating Patients With Stage IV HLA-A2 and HER2 Positive Breast or Ovarian Cancer Receiving TrastuzumabThis phase I/II trial studies the side effects of vaccine therapy and to see how well it works in treating patients with stage IV major histocompatibility complex, class I, A2…NCT00194714·Seattle, Washington

CompletedDocetaxel and Carboplatin as First-line Chemotherapy in Early Stage as Well as Advanced or Metastatic Ovarian CancerPrimary objective: To assess response rate. To record the clinical improvement in relation to stage and histopathological grading.NCT00452985·Dhaka

CompletedRO4929097 in Treating Patients With Recurrent and/or Metastatic Epithelial Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal CancerThis phase II trial is studying the side effects and how well RO4929097 works in treating patients with recurrent and/or metastatic epithelial ovarian cancer, fallopian tube…NCT01175343·Beverly Hills, California and 11 others

UnknownLong-acting G-CSF for Febrile NeutropeniaThis study aims to analyze the effects of long-acting granulocyte colony stimulating factor (G-CSF) on the prevention febrile neutropenia (FN) in epithelial ovarian cancer.NCT03740464·Beijing, Beijing Municipality

UnknownVirtual Trial to Compare Two Digital Therapeutics as Interventions for Physical and Mental Health in People With CancerThis is a 2-arm randomized controlled study comparing how effective two therapeutic digital software devices are at improving anxiety and other indicators of psychological and…NCT05227898·San Francisco, California

CompletedBreast Cancer in Poland: An Expanded Study to Assess Occupational and Environmental Factors and Interactions With GeneticsThe Polish breast, ovarian and endometrial cancer study is a complex molecular epidemiologic study that is expected to enroll about 2,500 breast cancer, 450 ovarian and 450…NCT00341458·Lodz and 1 other

RecruitingTC or BEP in Treating Patients With Malignant Ovarian Germ Cell TumorsInvestigators will conduct the trial to determine whether paclitaxel and cisplatin (PT) has the same curative effects and less adverse effects than bleomycin, etoposide and…NCT02429687·Jinan, Shandong

PreviousPage 202 of 203Next